3D-Printed Microfluidics Potential in Combating Future and Current
Pandemics (COVID-19)

Heba   A.   Eassa; Nada   A.   Helal; Ahmed   M.   Amer; Aliaa      Fouad; Asser   F.   Bedair; Reem      Nagib; Ihab      Mansoor; Motaz      Hawash; Maha      Abdul-Latif; Kamilia   H.A.   Mohammed; Mohamed   A.   Helal; Mohamed   Ismail   Nounou
doi:10.2174/2667387816666220727101214
Abstract

Coronavirus disease (COVID-19) emerged in China in December 2019. In March 2020, the WHO declared it a pandemic leading to worldwide lockdowns and travel restrictions. By May, it infected 4,789,205 and killed 318,789 people. This led to severe shortages in the medical sector besides devastating socio-economic effects. Many technologies such as artificial intelligence (AI), virtual reality (VR), microfluidics, 3D printing, and 3D scanning can step into contain the virus and hinder its extensive spread. This article aims to explore the potentials of 3D printing and microfluidic in accelerating the diagnosis and monitoring of the disease and fulfilling the shortages of personal protective equipment (PPE) and medical equipment. It highlights the main applications of 3D printers and microfluidics in providing PPE (masks, respirators, face shields, goggles, and isolation chambers/hoods), supportive care (respiratory equipment) and diagnostic supplies (sampling swabs & lab-on-chip) to ease the COVID-19 pressures. Also, the cost of such technology and regulation considerations are addressed. We conclude that 3D printing provided reusable and low-cost solutions to mitigate the shortages. However, safety, sterility, and compatibility with environmental protection standards need to be guaranteed through standardization and assessment by regulatory bodies. Finally, lessons learned from this pandemic can also help the world prepare for upcoming outbreaks.
Keywords: 3D printing, artificial intelligence (AI), COVID-19, microfluidics, pandemic, personal protective equipment (PPE), virtual reality (VR).
« Previous Next »
Graphical Abstract

[1]
Graversen VK, Hamichi SE, Gold A, Murray TG. History through the eyes of a pandemic. Curr Opin Ophthalmol  2020; 31(6): 538-48.
 [http://dx.doi.org/10.1097/ICU.0000000000000711] [PMID: 33009087]

[2]
Akin L, Gözel MG. Understanding dynamics of pandemics. Turk J Med Sci  2020; 50(SI-1): 515-9.
 [http://dx.doi.org/10.3906/sag-2004-133] [PMID: 32299204]

[3]
Webb SG. Prehistoric eye disease (trachoma?) in Australian aborigines. Am J Phys Anthropol  1990; 81(1): 91-100.
 [http://dx.doi.org/10.1002/ajpa.1330810110] [PMID: 2405692]

[4]
 World Health Organization (WHO). Smallpox. Geneva, Switzerland, 2021. Available from: https://www.who.int/health-topics/smallpox#tab=tab_1

[5]
 World Health Organization (WHO). Cholera. Geneva, Switzerland: 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/cholera

[6]
Barbieri R, Signoli M, Chevé D, et al. Yersinia pestis: The natural history of plague. Clin Microbiol Rev  2020; 34(1): e00044-19.
 [http://dx.doi.org/10.1128/CMR.00044-19] [PMID: 33298527]

[7]
Namouchi A, Guellil M, Kersten O, et al. Integrative approach using Yersinia pestis genomes to revisit the historical landscape of plague during the medieval period. Proc Natl Acad Sci USA  2018; 115(50): E11790-7.
 [http://dx.doi.org/10.1073/pnas.1812865115] [PMID: 30478041]

[8]
 UNAIDS. Global HIV & AIDS statistics — 2020 fact sheet. UNAIDS 2020. Available from: https://www.unaids.org/en/resources/fact-sheet

[9]
Zappa A, Amendola A, Romanò L, Zanetti A. Emerging and re-emerging viruses in the era of globalisation. Blood Transfus  2009; 7(3): 167-71.
 [PMID: 19657478]

[10]
 World Health Organization (WHO). Past pandemics. Geneva, Switzerland, 2009. Available from: https://apps.who.int/iris/bitstream/handle/10665/78414/9789241503051_eng.pdf

[11]
Davison AJ. Journal of general virology - introduction to ‘ICTV virus taxonomy profiles’. J Gen Virol  2017; 98(1): 1.
 [http://dx.doi.org/10.1099/jgv.0.000686] [PMID: 28218575]

[12]
 International Committee on Taxonomy of Viruses (ICTV). Berlin, Germany: Virus taxonomy 2019. Available from: https://talk.ictvonline.org/taxonomy/p/taxonomy_releases

[13]
van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med  2004; 10(4): 368-73.
 [http://dx.doi.org/10.1038/nm1024] [PMID: 15034574]

[14]
Kimberlin DW. Red Book: 2018-2021 Report of the committee on infectious diseases. USA. American Academy of Pediatrics  2018: pp. 297-301.

[15]
Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology  2018; 23(2): 130-7.
 [http://dx.doi.org/10.1111/resp.13196] [PMID: 29052924]

[16]
Yadav T, Saxena S K. Transmission cycle of SARS-CoV and SARS-CoV-2. Coronavirus Disease 2019 (COVID-19) 2020; 33- 42.

[17]
Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med  2003; 348(20): 1977-85.
 [http://dx.doi.org/10.1056/NEJMoa030666] [PMID: 12671062]

[18]
 World Health Organization (WHO). Summary table of SARS cases by country, 1 November 2002 - 7 August 2003. Geneva, Switzerland, 2003. Available from:  https://www.who.int/publications/m/item/summary-of-probable-sars-cases-with-onset-of-illness-from-1-november-2002-to-31-july-2003

[19]
Woo PC, Lau SK, Chu CM, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol  2005; 79(2): 884-95.
 [http://dx.doi.org/10.1128/JVI.79.2.884-895.2005] [PMID: 15613317]

[20]
Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev  2015; 28(2): 465-522.
 [http://dx.doi.org/10.1128/CMR.00102-14] [PMID: 25810418]

[21]
Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med  2012; 367(19): 1814-20.
 [http://dx.doi.org/10.1056/NEJMoa1211721] [PMID: 23075143]

[22]
 World Health Organization (WHO). Middle East respiratory syndrome coronavirus (MERS-CoV), MERS global summary and assessment of risk. Geneva, Switzerland, 2019. Available form: https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers#tab=tab_1

[23]
 World Health Organization (WHO). WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS): Updated recommendations, October 2004. Geneva, Switzerland, 2004. Available from: https://www.who.int/publications/i/item/who-guidelines-for-the-global-surveillance-of-severe-acuterespiratory- syndrome-(-sars)

[24]
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature  2020; 579(7798): 270-3.
 [http://dx.doi.org/10.1038/s41586-020-2012-7] [PMID: 32015507]

[25]
  World Health Organization (WHO). Novel coronavirus (2019- nCoV) situation Report-11. Geneva, Switzerland, 2020. Available from: https://apps.who.int/iris/handle/10665/330776

[26]
 World Health Organization (WHO). WHO Timeline - COVID-19. Geneva, Switzerland, 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline

[27]
Li X, Wang W, Zhao X, et al. Transmission dynamics and evolutionary history of 2019-nCoV. J Med Virol  2020; 92(5): 501-11.
 [http://dx.doi.org/10.1002/jmv.25701] [PMID: 32027035]

[28]
Ludwig S, Zarbock A. Coronaviruses and SARS-CoV-2: A brief overview. Anesth Analg  2020; 131(1): 93-6.
 [http://dx.doi.org/10.1213/ANE.0000000000004845] [PMID: 32243297]

[29]
Rabaan AA, Al-Ahmed SH, Haque S, et al. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Infez Med  2020; 28(2): 174-84.
 [PMID: 32275259]

[30]
Magrone T, Magrone M, Jirillo E. Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target- A perspective. Endocr Metab Immune Disord Drug Targets  2020; 20(6): 807-11.
 [http://dx.doi.org/10.2174/1871530320666200427112902] [PMID: 32338224]

[31]
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res  2020; 24: 91-8.
 [http://dx.doi.org/10.1016/j.jare.2020.03.005] [PMID: 32257431]

[32]
 Worldmeter COVID-19 coronavirus pandemic. 2020. Available from: https://www.worldometers.info/coronavirus/

[33]
Majid S, Khan MS, Rashid S, et al. COVID-19: Diagnostics, therapeutic advances, and vaccine development. Curr Clin Microbiol Rep  2021; 8(3): 152-66.
 [http://dx.doi.org/10.1007/s40588-021-00157-9] [PMID: 33614398]

[34]
 World Health Organization (WHO). Coronavirus disease (COVID- 19): Vaccines. Geneva, Switzerland, 2021. Availabe from: https://covid19.who.int/region/euro/country/ch

[35]
 UK Health Security Agency. COVID-19 vaccine surveillance report published. 2021. Available from: https://www.gov.uk/government/publications/covid-19-vaccine-weekly-surveillance-reports

[36]
Kuppalli K, Gala P, Cherabuddi K, et al. India’s COVID-19 crisis: A call for international action. Lancet  2021; 397(10290): 2132-5.
 [http://dx.doi.org/10.1016/S0140-6736(21)01121-1] [PMID: 34000256]

[37]
Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr  2021; 15(4): 102146.
 [http://dx.doi.org/10.1016/j.dsx.2021.05.019] [PMID: 34192610]

[38]
Nicola M, Alsafi Z, Sohrabi C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg  2020; 78: 185-93.
 [http://dx.doi.org/10.1016/j.ijsu.2020.04.018] [PMID: 32305533]

[39]
Elavarasan MR, Pugazhendhi R. Restructured society and environment: A review on potential technological strategies to control the COVID-19 pandemic. Sci Total Environ  2020; 725: 138858-8.
 [http://dx.doi.org/10.1016/j.scitotenv.2020.138858] [PMID: 32336562]

[40]
Tse LV, Meganck RM, Graham RL, Baric RS. The current and future state of vaccines, antivirals and gene therapies against emerging coronaviruses. Front Microbiol  2020; 11: 658.
 [http://dx.doi.org/10.3389/fmicb.2020.00658] [PMID: 32390971]

[41]
Santacroce L, Bottalico L, Charitos IA. The impact of COVID-19 on Italy: A lesson for the future. Int J Occup Environ Med  2020; 11(3): 151-2.
 [http://dx.doi.org/10.34172/ijoem.2020.1984] [PMID: 32225178]

[42]
Radonovich LJ, Magalian PD, Hollingsworth MK, Baracco G. Stockpiling supplies for the next influenza pandemic. Emerg Infect Dis  2009; 15(6): e1.
 [http://dx.doi.org/10.3201/eid1506.081196] [PMID: 21970033]

[43]
Vaishya R, Haleem A, Vaish A, Javaid M. Emerging technologies to combat the COVID-19 pandemic. J Clin Exp Hepatol  2020; 10(4): 409-11.
 [http://dx.doi.org/10.1016/j.jceh.2020.04.019] [PMID: 32377057]

[44]
Arora N, Banerjee AK, Narasu ML. The role of artificial intelligence in tackling COVID-19. Future Virol  2020; 15(11): 717-24.
 [http://dx.doi.org/10.2217/fvl-2020-0130]

[45]
Javaid M, Haleem A, Vaishya R, Bahl S, Suman R, Vaish A. Industry 4.0 technologies and their applications in fighting COVID-19 pandemic. Diabetes Metab Syndr  2020; 14(4): 419-22.
 [http://dx.doi.org/10.1016/j.dsx.2020.04.032] [PMID: 32344370]

[46]
Evans CJ. Precision engineering: An evolutionary perspective. Philos Trans- Royal Soc, Math Phys Eng Sci  2012(370): (1973) 3835-.
 [http://dx.doi.org/10.1098/rsta.2011.0050] [PMID: 22802493]

[47]
Ho CM, Ng SH, Li KH, Yoon YJ. 3D printed microfluidics for biological applications. Lab Chip  2015; 15(18): 3627-37.
 [http://dx.doi.org/10.1039/C5LC00685F] [PMID: 26237523]

[48]
Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science  2020; 368(6493): 860-8.
 [http://dx.doi.org/10.1126/science.abb5793] [PMID: 32291278]

[49]
 The International Organization for Standardization (ISO). ISO/ASTM 52900. Principles. 2015. Available from: https://www.iso.org/standard/69669.html

[50]
Lee J, An J, Chua CK. Fundamentals and applications of 3D printing for novel materials. Appl Mater Today  2017; 7: 120-33.
 [http://dx.doi.org/10.1016/j.apmt.2017.02.004]

[51]
Liaw CY, Guvendiren M. Current and emerging applications of 3D printing in medicine. Biofabrication  2017; 9(2): 024102.
 [http://dx.doi.org/10.1088/1758-5090/aa7279] [PMID: 28589921]

[52]
Tack P, Victor J, Gemmel P, Annemans L. 3D-printing techniques in a medical setting: A systematic literature review. Biomed Eng Online  2016; 15(1): 115.
 [http://dx.doi.org/10.1186/s12938-016-0236-4] [PMID: 27769304]

[53]
Makowski K, Okrasa M. Application of 3D scanning and 3D printing for designing and fabricating customized half-mask facepieces: A pilot study. Work  2019; 63(1): 125-35.
 [http://dx.doi.org/10.3233/WOR-192913] [PMID: 31127750]

[54]
Swennen GRJ, Pottel L, Haers PE. Custom-made 3D-printed face masks in case of pandemic crisis situations with a lack of commercially available FFP2/3 masks. Int J Oral Maxillofac Implants  2020; 49(5): 673-7.
 [http://dx.doi.org/10.1016/j.ijom.2020.03.015] [PMID: 32265088]

[55]
Srinivasan A, Jernign DB, Liedtke L, Strausbaugh L. Hospital preparedness for severe acute respiratory syndrome in the United States: Views from a national survey of infectious diseases consultants. Clin Infect Dis  2004; 39(2): 272-4.
 [http://dx.doi.org/10.1086/421777] [PMID: 15307038]

[56]
Food US. U.S. Food and Drug Adminstration (FDA). FDA recall: Smart Lipo365 issues voluntary nationwide recall of smart lipo due to undeclared sibutramine, desmethylsibutramine and phenolphthalein. Human Drug Information. Silver Spring, MD 20993 USA: Maryland, U.S.A. Division of Drug Information (CDER), 2015.

[57]
Kotta S, Nair A, Alsabeelah N. 3D printing technology in drug delivery: Recent progress and application. Curr Pharm Des  2018; 24(42): 5039-48.
 [http://dx.doi.org/10.2174/1381612825666181206123828] [PMID: 30520368]

[58]
Prasad LK, Smyth H III. 3D Printing technologies for drug delivery: A review. Drug Dev Ind Pharm  2016; 42(7): 1019-31.
 [http://dx.doi.org/10.3109/03639045.2015.1120743] [PMID: 26625986]

[59]
 World Health Organization (WHO). Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages: Interim guidance, 6 April 2020. Geneva, Switzerland, 2020. Available from: https://www.who.int/publications/i/item/rational-use-of-personal-protective-equipment-for-coronavirus-disease-(covid-19)-and-considerations-during-severe-shortages

[60]
 Centers for disease control and prevention (CDC). Recommendation regarding the use of cloth face coverings, especially in areas of significant community-based transmission. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover.html (Accessed on: May 29, 2021).

[61]
 Al Jazeera. Which countries have made wearing face masks compulsory? Available from: https://www.aljazeera.com/news/2020/04/countries-wearing-face-masks-compulsory-200423094510867.html (Accessed on: May 29, 2021).

[62]
 Nippon (nippon.com). Japan Govt to give 2 masks to every household over virus. Available from: https://www.nippon.com/en/news/yjj2020040101147/japan-govt-to-give-2-masks-to-every-household-over-virus.html (Accessed on: May 27, 2021).

[63]
Konda A, Prakash A, Moss GA, Schmoldt M, Grant GD, Guha S. Aerosol filtration efficiency of common fabrics used in respiratory cloth masks. ACS Nano  2020; 14(5): 6339-47.
 [http://dx.doi.org/10.1021/acsnano.0c03252] [PMID: 32329337]

[64]
MacIntyre CR, Seale H, Dung TC, et al. A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open  2015; 5(4): e006577.
 [http://dx.doi.org/10.1136/bmjopen-2014-006577] [PMID: 25903751]

[65]
Provenzano D, Rao YJ, Mitic K, et al. Rapid prototyping of reusable 3D-printed N95 equivalent respirators at the George Washington University. Preprints  2020; 2020; 2020030444.

[66]
Cai M, Li H, Shen S, Wang Y, Yang Q. Customized design and 3D printing of face seal for an N95 filtering facepiece respirator. J Occup Environ Hyg  2018; 15(3): 226-34.
 [http://dx.doi.org/10.1080/15459624.2017.1411598] [PMID: 29194018]

[67]
Bovenzi T.  Cedarville student 3D-printing N95 masks for healthcare professionals. Available from: https://spectrumnews1.com/oh/columbus/news/2020/04/02/cedarville-student-3d-printing-n95-masks-for-healthcare-professionals (Accessed on: Apr. 02, 2020).

[68]
Liu DCY, Koo TH, Wong JKK, et al. Adapting re-usable elastomeric respirators to utilise anaesthesia circuit filters using a 3D-printed adaptor - a potential alternative to address N95 shortages during the COVID-19 pandemic. Anaesthesia  2020; 75(8): 1022-7.
 [http://dx.doi.org/10.1111/anae.15108] [PMID: 32348561]

[69]
Erickson MM, Richardson ES, Hernandez NM, Bobbert DW II, Gall K, Fearis P. Helmet modification to PPE with 3D printing during the COVID-19 pandemic at Duke University medical center: A novel technique. J Arthroplasty  2020; 35(7S): S23-7.
 [http://dx.doi.org/10.1016/j.arth.2020.04.035] [PMID: 32354536]

[70]
Kroo L, Kothari A, Hannebelle M, et al. Pneumask: Modified full-face snorkel masks as reusable personal protective equipment for hospital personnel. medRxiv  2020; 2020; 2020.04.24.20078907.

[71]
 ElNacional(ElNacional.cat). ElNacional coronavirus | Hospital de Sant Pau receives 3D face masks to protect healthcare professionals. Available from: https://www.elnacional.cat/en/news/corona virus-hospital-sant-pau-receives-3d-masks_489024_102.html (Accessed on: May 29).

[72]
Germonpre P, Van Rompaey D, Balestra C. Evaluation of protection level, respiratory safety, and practical aspects of commercially available snorkel masks as personal protection devices against aerosolized contaminants and SARS-CoV2. Int J Environ Res Public Health  2020; 17(12): E4347.
 [http://dx.doi.org/10.3390/ijerph17124347] [PMID: 32575366]

[73]
Nicholson K, Henke-Adams A, Henke DM, Kravitz AV, Gay HA. Modified full-face snorkel mask as COVID-19 personal protective equipment: Quantitative results. Preprints  2020; 2020; 2020040293.

[74]
Greig PR, Carvalho C, El-Boghdadly K, Ramessur S. Safety testing improvised COVID-19 personal protective equipment based on a modified full-face snorkel mask. Anaesthesia  2020; 75(7): 970-1.
 [http://dx.doi.org/10.1111/anae.15085] [PMID: 32275770]

[75]
Elkington P, Dickinson A, Mavrogordato M, et al. A personal respirator specification for health-care workers treating COVID-19 (PeRSo). Front Med Technol  2021; 3: 664259.

[76]
Sapoval M, Gaultier AL, Del Giudice C, et al. 3D-printed face protective shield in interventional radiology: Evaluation of an immediate solution in the era of COVID-19 pandemic. Diagn Interv Imaging  2020; 101(6): 413-5.
 [http://dx.doi.org/10.1016/j.diii.2020.04.004] [PMID: 32354631]

[77]
Mostaghimi A, Antonini M-J, Plana D, et al. Rapid prototyping and clinical testing of a reusable face shield for health care workers responding to the COVID-19 pandemic. medRxiv  2020; 2020; 20061960.
 [http://dx.doi.org/10.1101/2020.04.11.20061960]

[78]
Wesemann C, Pieralli S, Fretwurst T, et al. 3-D printed protective equipment during COVID-19 pandemic. Materials (Basel)  2020; 13(8): E1997.
 [http://dx.doi.org/10.3390/ma13081997] [PMID: 32344688]

[79]
Amin D, Nguyen N, Roser S M, Abramowicz S. 3D printing of face shields during COVID-19 pandemic: A technical note. J Oral Maxillofac Surg 2020; 0278-2391(20): 30446-8.

[80]
Maracaja L, Blitz D, Maracaja DLV, Walker CA. How 3D printing can prevent spread of COVID-19 among healthcare professionals during times of critical shortage of protective personal equipment. J Cardiothorac Vasc Anesth  2020; 34(10): 2847-9.
 [http://dx.doi.org/10.1053/j.jvca.2020.04.004] [PMID: 32381308]

[81]
 Asia Pacific Defence Reporter (APDR). Australian army pivots to
making 3D-printed face shields for COVID-19 fight. Available
from:https://asiapacificdefencereporter.com/australian-army-pivots-to-making-3d-printed-face-shields-for-covid-19-fight/ (Accessed
on: May 28, 2021).

[82]
 America’s Navy. Naval air systems command public affairs navy,
marine corps partner with industry, fema to 3-D print face shields.
Available from: https://www.navy.mil/submit/display.asp? story_id=112514 (Accessed on: May 28, 2021).

[83]
 Business insider. Tech companies like apple and blue origin and
universities like Duke are using their arsenals of 3D printers to
produce millions of face shields for medical workers. Available
from: https://www.businessinsider.com/face-shields-coronavirus-medical-workers-apple-blue-origin-harvard-ford-2020-4 (Accessed
on: May 28, 2021).

[84]
Cox JL, Koepsell SA. 3D-printing to address COVID-19 testing supply shortages. Lab Med  2020; 51(4): e45-6.
 [http://dx.doi.org/10.1093/labmed/lmaa031] [PMID: 32386057]

[85]
Gallup N, Pringle AM, Oberloier S, Tanikella NG, Pearce JM.  Parametric nasopharyngeal swab for sampling COVID-19 and other respiratory viruses: Open source design, SLA 3-D printing and UV curing system. Michigan Tech 2017; Available from: https://digitalcommons.mtu.edu/michigantech-p/2107/

[86]
Callahan CJ, Lee R, Zulauf K, et al. Open development and clinical validation of multiple 3D-printed nasopharyngeal collection swabs: Rapid resolution of a critical COVID-19 testing bottleneck. medRxiv  2020; 2020: 1.

[87]
Clarke AL. 3D printed circuit splitter and flow restriction devices for multiple patient lung ventilation using one anaesthesia workstation or ventilator. Anaesthesia  2020; 75(6): 819-20.
 [http://dx.doi.org/10.1111/anae.15063] [PMID: 32233030]

[88]
Faryami A, Harris CA. Open source 3D printed ventilation device. bioRxiv  2020; 2020; 2020.05.21.

[89]
Cavallo L, Marcianò A, Cicciù M, Oteri G. 3D printing beyond dentistry during COVID 19 epidemic: A technical note for producing connectors to breathing devices. J Prosthesis  2020; 2(2): 46-52.
 [http://dx.doi.org/10.3390/prosthesis2020005]

[90]
Gonzalez-Gonzalez E, Lara-Mayorga IM, Yee-de Leon F, et al. Scaling diagnostics in times of COVID-19: Colorimetric loop-mediated isothermal amplification (LAMP) assisted by a 3D-printed incubator for cost-effective and scalable detection of SARS-CoV-2. medRxiv  2020; 2020; 20058651.
 [http://dx.doi.org/10.1101/2020.04.09.20058651]

[91]
Bennett I, Bulterys PL, Chang M, et al. The rapid deployment of a 3D printed latticed nasopharyngeal swab for COVID-19 testing made using digital light synthesis. medRxiv  2020; 2020; 20112201.

[92]
 SASAC. State-owned assets supervision and administration commission vanguard increases 3D printing medical goggles production. Available from: http://en.sasac.gov.cn/2020/03/03/c_3967.htm (Accessed on: May 28, 2021).

[93]
  Farsoon Technologies (en.farsoon.com). Farsoon, huaxiang & LEHVOSS group additively manufacture safety goggles to fight COVID-19. Available from: en.farsoon.com Available from:  http://en.farsoon.com/news_detail/newsId=140.html (Accessed on: May 28, 2021). 

[94]
Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the difficult airway society, the association of anaesthetists the intensive care society, the faculty of intensive care medicine and the Royal College of anaesthetists. Anaesthesia  2020; 75(6): 785-99.
 [http://dx.doi.org/10.1111/anae.15054] [PMID: 32221970]

[95]
Cubillos J, Querney J, Rankin A, Moore J, Armstrong K. A multipurpose portable negative air flow isolation chamber for aerosol-generating procedures during the COVID-19 pandemic. Br J Anaesth  2020; 125(1): e179-81.
 [http://dx.doi.org/10.1016/j.bja.2020.04.059] [PMID: 32386834]

[96]
Le HD, Novak GA, Janek KC, et al. A novel box for aerosol and droplet guarding and evacuation in respiratory infection (BADGER): A potential mitigating strategy for the COVID-19 pandemic and future outbreaks. medRxiv  2020; 2020; 2020.05.09.20096032.

[97]
Iyengar K, Bahl S. Raju Vaishya, Vaish A. Challenges and solutions in meeting up the urgent requirement of ventilators for COVID-19 patients. Diabetes Metab Syndr  2020; 14(4): 499-501.
 [http://dx.doi.org/10.1016/j.dsx.2020.04.048] [PMID: 32388328]

[98]
Srinivasan S, Ramadi KB, Vicario F, et al. Individualized system for augmenting ventilator efficacy (iSAVE): A rapidly deployable system to expand ventilator capacity. bioRxiv  2020; 2020; 2020.03.28.012617.
 [http://dx.doi.org/10.1101/2020.03.28.012617]

[99]
Routhier R.  SMCC professor creates device to help with shortage of ventilators Available from: https://www.pressherald.com/2020/03/26/smcc-professor-creates-device-to-help-with-ventilator-shortage/# (Accessed on: March 26, 2021).

[100]
Tino R, Moore R, Antoline S, et al. COVID-19 and the role of 3D printing in medicine. 3D Print Med 2020; 6(1): 11.

[101]
Pearce JM. A review of open source ventilators for COVID-19 and future pandemics. F1000 Res  2020; 9: 218-8.
 [http://dx.doi.org/10.12688/f1000research.22942.2] [PMID: 32411358]

[102]
Peters J.  Volunteers produce 3D-printed valves for life-saving coronavirus treatments. Available from: https://www.theverge.com/platform/amp/2020/3/17/21184308/coronavirus-italy-medical-company-threatens-sue-3d-print-valves-treatments (Accessed on: March 17, 2021).

[103]
 Dailymail. Tim stickings for mailonline the ventilators made from snorkelling masks: Italian engineers make emergency medical gear with 3D-printed valves to help hospitals battle coronavirus. Available from: https://www.dailymail.co.uk/news/article-8143099/The-ventilators-diving-masks-Italy.html?ito=social-facebook

[104]
Graham C.  Johns Hopkins engineers develop 3d-printed ventilator splitters. 2020, Available from: https://hub.jhu.edu/2020/04/02/3d-printed-ventilator-splitters-for-covid-19/

[105]
Clarke AL, Stephens AF, Liao S, Byrne TJ, Gregory SD. Coping with COVID-19: Ventilator splitting with differential driving pressures using standard hospital equipment. Anaesthesia  2020; 75(7): 872-80.
 [http://dx.doi.org/10.1111/anae.15078] [PMID: 32271942]

[106]
 Agorize (get.agorize.com). Code life ventilator challenge: To design a low-cost, simple, easy-to-use and easy-to-build ventilator that can serve the COVID patients, in an emergency timeframe. Available from: get.agorize.com Available from: https://www.agorize.com/en/challenges/code-life-challenge

[107]
 Innovation hub (iHub). Ventilator design challenge. Available from: http://ihub.asu.edu.eg/ventilator-design-challenge.html? fbclid= IwAR0pmO7ZfD4R87wYmnI5DrX0UmKqqCAqUGEiiX-NMXJZ nBe8gCWygN1vHgU

[108]
Nairz M, Bellmann-Weiler R, Ladstätter M, et al. Overcoming limitations in the availability of swabs systems used for SARS-CoV-2 laboratory diagnostics. Res Square  2020; 2020: 2261.
 [http://dx.doi.org/10.21203/rs.3.rs-37549/v1]

[109]
Singh S, Prakash C, Ramakrishna S. Three-dimensional printing in the fight against novel virus COVID-19: Technology helping society during an infectious disease pandemic. Technol Soc  2020; 62: 101305.
 [http://dx.doi.org/10.1016/j.techsoc.2020.101305] [PMID: 32834232]

[110]
Hass KN, Bao M, He Q, Park M, Qin P, Du K. Integrated micropillar polydimethylsiloxane accurate CRISPR detection (IMPACT) system for rapid viral DNA sensing. bioRxiv  2020; 2020; 2020.03.17.994137.
 [http://dx.doi.org/10.1101/2020.03.17.994137]

[111]
Udugama B, Kadhiresan P, Kozlowski HN, et al. Diagnosing COVID-19: The disease and tools for detection. ACS Nano  2020; 14(4): 3822-35.
 [http://dx.doi.org/10.1021/acsnano.0c02624] [PMID: 32223179]

[112]
Nelson PP, Rath BA, Fragkou PC, Antalis E, Tsiodras S, Skevaki C. Current and future point-of-care tests for emerging and new respiratory viruses and future perspectives. Front Cell Infect Microbiol  2020; 10(181): 181.
 [http://dx.doi.org/10.3389/fcimb.2020.00181] [PMID: 32411619]

[113]
Nguyen T, Duong Bang D, Wolff A. 2019 novel coronavirus disease (COVID-19): Paving the road for rapid detection and point-of-care diagnostics. Micromachines (Basel)  2020; 11(3): 306.
 [http://dx.doi.org/10.3390/mi11030306] [PMID: 32183357]

[114]
Sharma S, Kumar V, Chawla A, Logani A. Rapid detection of SARS-CoV-2 in saliva: Can an endodontist take the lead in point-of-care COVID-19 testing? Int Endod J  2020; 53(7): 1017-9.
 [http://dx.doi.org/10.1111/iej.13317] [PMID: 32344452]

[115]
Zhuang J, Yin J, Lv S, Wang B, Mu Y. Advanced “lab-on-a-chip” to detect viruses - Current challenges and future perspectives. Biosens Bioelectron  2020; 163: 112291.
 [http://dx.doi.org/10.1016/j.bios.2020.112291] [PMID: 32421630]

[116]
Morales-Narváez E, Dincer C. The impact of biosensing in a pandemic outbreak: COVID-19. Biosens Bioelectron  2020; 163: 112274.
 [http://dx.doi.org/10.1016/j.bios.2020.112274] [PMID: 32421627]

[117]
Sakai J, Tarumoto N, Orihara Y, et al. Evaluation of a high-speed but low-throughput RT-qPCR system for SARS-CoV-2 detection. J Hosp Infect  2020; 2020: 25.
 [http://dx.doi.org/10.1016/j.jhin.2020.05.025] [PMID: 32446722]

[118]
Broughton JP, Deng X, Yu G, et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol  2020; 38(7): 870-4.
 [http://dx.doi.org/10.1038/s41587-020-0513-4] [PMID: 32300245]

[119]
Ramachandran A, Huyke DA, Sharma E, et al. Electric-field-driven microfluidics for rapid CRISPR-based diagnostics and its application to detection of SARS-CoV-2. bioRxiv  2020; 2020; 109637.
 [http://dx.doi.org/10.1101/2020.05.21.109637]

[120]
Tan X, Lin C, Zhang J, Khaing Oo MK, Fan X. Rapid and quantitative detection of COVID-19 markers in micro-liter sized samples. bioRxiv  2020; 2020; 2020.04.20.052233.
 [http://dx.doi.org/10.1101/2020.04.20.052233]

[121]
 Grand Veiw research (grandreviewresearch.com). 3D printing market size, share & trends analysis report by material, by component (Hardware, Services), by printer type (desktop, industrial), by technology, by software, by application, by vertical, and Segment Forecasts 2021-2028; 2021, Available form: https://www.marketresearch.com/Grand-View-Research-v4060/3D-Printing-Size-Share-Trends-14624247/

[122]
Vitali J, Cheng M, Wagels M. Utility and cost–effectiveness of 3D-printed materials for clinical use. Journal of 3D Printing in Medicine 2019; 3(4): 209-18.

[123]
Angevine PD, Berven S. Health economic studies: An introduction to cost-benefit, cost-effectiveness, and cost-utility analyses. Spine  2014; 39(22) (Suppl. 1): S9-S15.
 [http://dx.doi.org/10.1097/BRS.0000000000000576] [PMID: 25299265]

[124]
Ventola CL. Medical applications for 3D printing: Current and projected uses. P&T  2014; 39(10): 704-11.
 [PMID: 25336867]

[125]
Choonara YE, du Toit LC, Kumar P, Kondiah PPD, Pillay V. 3D-printing and the effect on medical costs: A new era? Expert Rev Pharmacoecon Outcomes Res  2016; 16(1): 23-32.
 [http://dx.doi.org/10.1586/14737167.2016.1138860] [PMID: 26817398]

[126]
Rathi C.  Traditional manufacturing vs. 3D printing: A cost analysis. Available from: https://precious3d.com/traditional-manufacturing-vs-3d-printing/ (Accessed on: May 28, 2020).

[127]
Awad A, Trenfield SJ, Goyanes A, Gaisford S, Basit AW. Reshaping drug development using 3D printing. Drug Discov Today  2018; 23(8): 1547-55.
 [http://dx.doi.org/10.1016/j.drudis.2018.05.025] [PMID: 29803932]

[128]
Thomas D. Costs, benefits, and adoption of additive manufacturing: A supply chain perspective. Int J Adv Manuf Technol  2016; 85(5-8): 1857-76.
 [http://dx.doi.org/10.1007/s00170-015-7973-6] [PMID: 28747809]

[129]
Soloman S. Additive Manufacturing-3D Printing & Design:-The 4th Industrial Revolution. Published by Sabrie Soloman 2020.

[130]
Fuges CM.  When is 3D printing cost effective? Available from: https://www.moldmakingtechnology.com/blog/post/when-is-3d-printing-cost-effective (Accessed on: May 28, 2021).

[131]
 EdexLive (edexlive.com). COVID-19: IIT Madras start-UPS develop PPEs made from 3D printers and common stationery materials. 2020. Available from: https://www.edexlive.com/campus/2020/apr/30/covid-19-iit-madras-start-ups-develop-ppes-made-from-3d-printers-and-common-stationery-materials-11697.html (Accessed on: May 28, 2020).

[132]
Kleinman Z.  Coronavirus: Can we 3D-print our way out of the PPE shortage? Available from: https://www.bbc.com/news/health-52201696 (Accessed on: May 28, 2020).

[133]
Clifton W, Damon A, Martin A. Considerations and cautions for three-dimensional-printed personal protective equipment in the COVID-19 crisis. 3D Print. Addit Manuf  2020; 7(3): 97-9.

[134]
 U.S. Food and Drug Adminstration (FDA). FDA efforts to connect manufacturers and health care entities: The FDA, department of veterans affairs, National Institutes of Health, and America makes form a COVID-19 response public-private partnership. Food Agent.Com 2020, Available form: https://food-agent.com/?gclid=Cj0KCQjwntCVBhDdARIsAMEwACkklwfF2c4MNK4sfmJCOTEHxUtpI00Zxvaab8eA7mPuDWRn_rdvFm4aAkDpEALw_wcB

[135]
Ebrahim TY. 3D printing: Digital infringement & digital regulation. Nw J Tech & Intell Prop  2016; 14: 37.

[136]
Berdine GG, DiPaola M, Weinberg M. Economic and regulatory perspectives on additive manufacturing In: 3D Printing in orthopaedic surgery.  Elsevier 2019; pp. 41-8.

[137]
Flanagan ST, Ballard DH. 3D printed face shields: A community response to the COVID-19 global pandemic. Acad Radiol  2020; 27(6): 905-6.
 [http://dx.doi.org/10.1016/j.acra.2020.04.020] [PMID: 32335004]

[138]
Payzant SG.  3D printing of medical devices: The regulatory challenges for manufacturers. Available from: https://www.rcri-inc.com/3dprinting/

[139]
Provenzano D, Rao YJ, Mitic K, et al. Alternative qualitative fit testing method for N95 equivalent respirators in the setting of resource scarcity at the George Washington University. medRxiv  2020; 2020; 2020.04.06.20055368.
 [http://dx.doi.org/10.1101/2020.04.06.20055368]

[140]
 U.S. Food and Drug Adminstration (FDA). Technical considerations for additive manufactured medical device. 2017. Available from: https://www.fda.gov/media/97633/download

[141]
 Department of Health and Human Services. Determination of Public Health Emergency. Available from: https://www.federalregister.gov/documents/2020/02/07/2020-02496/determination-of-public-health-emergency (Accessed on: July 1, 2021).

[142]
U.S. Food and Drug Adminstration (FDA). Emergency use authorization. In: MCM Legal, Regulatory and Policy Framework. Silver Spring, MD 20993, USA 2020.

[143]
U.S. Food and Drug Adminstration (FDA). FAQs on 3D printing of medical devices, accessories, components, and parts during the COVID-19 pandemic. In: Silver Spring, MD 20993, USA: U.S. 2020.

[144]
U.S. Food and Drug Adminstration (FDA). Enforcement policy for face masks and respirators during the coronavirus disease (COVID-19) public health emergency. In: Silver Spring, MD 20993, USA 2020.

[145]
Manero A, Smith P, Koontz A, et al. Leveraging 3D printing capacity in times of crisis: Recommendations for COVID-19 distributed manufacturing for medical equipment rapid response. Int J Environ Res Public Health  2020; 17(13): E4634.
 [http://dx.doi.org/10.3390/ijerph17134634] [PMID: 32605098]

[146]
Willemsen K, Nizak R, Noordmans HJ, Castelein RM, Weinans H, Kruyt MC. Challenges in the design and regulatory approval of 3D-printed surgical implants: A two-case series. Lancet Digit Health  2019; 1(4): e163-71.
 [http://dx.doi.org/10.1016/S2589-7500(19)30067-6] [PMID: 33323186]
Rights & Permissions Print Cite
Article Metrics
4
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/2667387816666220727101214	Print ISSN 2667-3878
Publisher Name Bentham Science Publisher	Online ISSN 2667-3886
Recent Advances in Drug Delivery and Formulation

3D-Printed Microfluidics Potential in Combating Future and Current Pandemics (COVID-19)

Abstract Play Pause

Graphical Abstract

Related Journals

Related Books

Abstract
